Đánh giá kết quả điều trị ung thư biểu mô tế bào gan không có khả năng cắt bỏ bằng đốt sóng cao tần có gây mê dưới hướng dẫn của siêu âm

Abstract

Objective: The study aimed to evaluate the results of treatment of hepatocellular carcinoma that cannot be resected by radiofrequency ablation with anesthesia and ultrasound guidance at Hue Central Hospital.        Subject and method: Prospective, interventional, uncontrolled study including 33 patients with confirmed diagnosis of hepatocellular carcinoma (HCC) who cannot be resected treated with radio frequency ablation from January 2020 to June 2021. Present some clinical characteristics of patients with HCC; evaluated the results of treatment of HCC that cannot be resectable with RFA under anesthesia under ultrasound guidance with the following results: Complete tumor destruction rate, tumor recurrence rate, progression-free time and no recurrence, overall survival time of patients in the study.           Result: Including 29 men and 4 women, the male:female ratio was 7.25:1. The mean age was 64.06 ± 11.21 (26 - 81). Total 39 tumors/ 33 patients, average size: 2.5 ± 0.9cm. The rate of complete tumor destruction in the first RFA was 89.7%, and 96.9% after 2 RFA. The rate of no tumor recurrence was 84.8%. Progression-free and recurrence-free disease time 7.7 ± 5.3 months, overall survival time 11.4 ± 3.9 months.          Conclusion: Radiofrequency ablation can bring good treatment effect and long survival time for patients with unresectable HCC.